What is Abbott's equity method investments (note 11)?

Abbott (ABT) reported equity method investments (note 11) of $151M in Q1 2026.

How has Abbott's equity method investments (note 11) changed year-over-year?

Abbott's equity method investments (note 11) decreased by 0.7% year-over-year, from $152M to $151M.

What is the long-term trend for Abbott's equity method investments (note 11)?

Over 3 years (2022 to 2025), Abbott's equity method investments (note 11) has grown at a -8.1% compound annual growth rate (CAGR), from $169M to $131M.

Abbott ABT Equity method investments (Note 11)

Equity method investments (Note 11) at other companies

Boston ScientificBSX

——

Edwards LifesciencesEW

——

MedtronicMDT

——

ResMedRMD

——

PfizerPFE

——

Other financials

Income statement

See full

Revenue$11.2B+7.8%

Gross profit$6.3B+6.5%

Operating income$1.3B-20.6%

Net income$1.1B-18.7%

EPS (diluted)$0.61-19.7%

Balance sheet

See full

Cash & equivalents$6.8B+4.2%

Total debt$34.0B+157%

Total equity$52.1B+6.7%

Total assets$110.43B+35.6%

Cash flow

See full

Operating cash flow$1.3B-7.2%

CapEx$399.0M-17.6%

Free cash flow$916.0M-1.8%

Valuation

See full

Market cap$154.15B-22.5%

Enterprise value$181.39B-13.1%

P/E24.6×+9.8×

P/S3.4×-1.3×

Profitability

See full

Gross margin56.3%+0.4pp

Operating margin17.1%+0.2pp

Net margin13.9%-18.0pp

Returns & leverage

See full

Return on equity12.4%-18.4pp

Debt / equity0.7×+0.4×

Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestments.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's equity method investments (note 11).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Abbott's equity method investments (note 11)?: Abbott (ABT) reported equity method investments (note 11) of $151M in Q1 2026.
How has Abbott's equity method investments (note 11) changed year-over-year?: Abbott's equity method investments (note 11) decreased by 0.7% year-over-year, from $152M to $151M.
What is the long-term trend for Abbott's equity method investments (note 11)?: Over 3 years (2022 to 2025), Abbott's equity method investments (note 11) has grown at a -8.1% compound annual growth rate (CAGR), from $169M to $131M.